250 related articles for article (PubMed ID: 22205974)
21. Discovery of novel, potent, and selective small-molecule CCR5 antagonists as anti-HIV-1 agents: synthesis and biological evaluation of anilide derivatives with a quaternary ammonium moiety.
Shiraishi M; Aramaki Y; Seto M; Imoto H; Nishikawa Y; Kanzaki N; Okamoto M; Sawada H; Nishimura O; Baba M; Fujino M
J Med Chem; 2000 May; 43(10):2049-63. PubMed ID: 10821717
[TBL] [Abstract][Full Text] [Related]
22. The Diagnostic Significance of PDGF, EphA7, CCR5, and CCL5 Levels in Colorectal Cancer.
Üçüncü M; Serilmez M; Sarı M; Bademler S; Karabulut S
Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31505877
[TBL] [Abstract][Full Text] [Related]
23. The CCL5/CCR5 axis contributes to the perineural invasion of human salivary adenoid cystic carcinoma.
Shen Z; Li T; Chen D; Jia S; Yang X; Liang L; Chai J; Cheng X; Yang X; Sun M
Oncol Rep; 2014 Feb; 31(2):800-6. PubMed ID: 24337063
[TBL] [Abstract][Full Text] [Related]
24. The CCL5/CCR5 Chemotactic Pathway Promotes Perineural Invasion in Salivary Adenoid Cystic Carcinoma.
Gao T; Shen Z; Ma C; Li Y; Kang X; Sun M
J Oral Maxillofac Surg; 2018 Aug; 76(8):1708-1718. PubMed ID: 29549020
[TBL] [Abstract][Full Text] [Related]
25. Antineoplastic effects of targeting CCR5 and its therapeutic potential for colorectal cancer liver metastasis.
Pervaiz A; Zepp M; Georges R; Bergmann F; Mahmood S; Faiza S; Berger MR; Adwan H
J Cancer Res Clin Oncol; 2021 Jan; 147(1):73-91. PubMed ID: 32902795
[TBL] [Abstract][Full Text] [Related]
26. CCL5 activation of CCR5 regulates cell metabolism to enhance proliferation of breast cancer cells.
Gao D; Rahbar R; Fish EN
Open Biol; 2016 Jun; 6(6):. PubMed ID: 27335323
[TBL] [Abstract][Full Text] [Related]
27. HIV entry inhibitor TAK-779 attenuates atherogenesis in low-density lipoprotein receptor-deficient mice.
van Wanrooij EJ; Happé H; Hauer AD; de Vos P; Imanishi T; Fujiwara H; van Berkel TJ; Kuiper J
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2642-7. PubMed ID: 16239591
[TBL] [Abstract][Full Text] [Related]
28. Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression.
Iida Y; Xu B; Xuan H; Glover KJ; Tanaka H; Hu X; Fujimura N; Wang W; Schultz JR; Turner CR; Dalman RL
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):718-26. PubMed ID: 23288157
[TBL] [Abstract][Full Text] [Related]
29. Alcohol consumption promotes colorectal carcinoma metastasis via a CCL5-induced and AMPK-pathway-mediated activation of autophagy.
Zhao H; Chen D; Cao R; Wang S; Yu D; Liu Y; Jiang Y; Xu M; Luo J; Wang S
Sci Rep; 2018 Jun; 8(1):8640. PubMed ID: 29872080
[TBL] [Abstract][Full Text] [Related]
30. CCL5-CCR5 interactions modulate metabolic events during tumor onset to promote tumorigenesis.
Gao D; Cazares LH; Fish EN
BMC Cancer; 2017 Dec; 17(1):834. PubMed ID: 29216863
[TBL] [Abstract][Full Text] [Related]
31. Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients.
Halama N; Zoernig I; Berthel A; Kahlert C; Klupp F; Suarez-Carmona M; Suetterlin T; Brand K; Krauss J; Lasitschka F; Lerchl T; Luckner-Minden C; Ulrich A; Koch M; Weitz J; Schneider M; Buechler MW; Zitvogel L; Herrmann T; Benner A; Kunz C; Luecke S; Springfeld C; Grabe N; Falk CS; Jaeger D
Cancer Cell; 2016 Apr; 29(4):587-601. PubMed ID: 27070705
[TBL] [Abstract][Full Text] [Related]
32. Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand-Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib.
Suenaga M; Schirripa M; Cao S; Zhang W; Yang D; Ning Y; Cremolini C; Antoniotti C; Borelli B; Mashima T; Okazaki S; Berger MD; Miyamoto Y; Gopez R; Barzi A; Lonardi S; Yamaguchi T; Falcone A; Loupakis F; Lenz HJ
Clin Colorectal Cancer; 2018 Jun; 17(2):e395-e414. PubMed ID: 29606345
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of KLF5 in cancer-associated fibroblasts inhibit gastric cancer cells progression by CCL5/CCR5 axis.
Yang T; Chen M; Yang X; Zhang X; Zhang Z; Sun Y; Xu B; Hua J; He Z; Song Z
Cancer Biol Ther; 2017 Oct; 18(10):806-815. PubMed ID: 28934010
[TBL] [Abstract][Full Text] [Related]
34. Cytokine CCL5 and receptor CCR5 axis in glioblastoma multiforme.
Kranjc MK; Novak M; Pestell RG; Lah TT
Radiol Oncol; 2019 Nov; 53(4):397-406. PubMed ID: 31747383
[TBL] [Abstract][Full Text] [Related]
35. CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency.
Li F; Sheng Y; Hou W; Sampath P; Byrd D; Thorne S; Zhang Y
J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32098828
[TBL] [Abstract][Full Text] [Related]
36. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
[TBL] [Abstract][Full Text] [Related]
37. Expression and biological functions of the CCL5-CCR5 axis in oral lichen planus.
Shan J; Li S; Wang C; Liu L; Wang X; Zhu D; Fan Y; Xu J
Exp Dermatol; 2019 Jul; 28(7):816-821. PubMed ID: 31006151
[TBL] [Abstract][Full Text] [Related]
38. Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels predict efficacy of bevacizumab in metastatic colorectal cancer patients.
Suenaga M; Cao S; Zhang W; Yang D; Ning Y; Okazaki S; Berger MD; Miyamoto Y; Schirripa M; Soni S; Barzi A; Yamaguchi T; Lenz HJ
Int J Cancer; 2019 May; 144(10):2567-2577. PubMed ID: 30411783
[TBL] [Abstract][Full Text] [Related]
39. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
40. The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function.
Ni J; Zhu YN; Zhong XG; Ding Y; Hou LF; Tong XK; Tang W; Ono S; Yang YF; Zuo JP
Br J Pharmacol; 2009 Dec; 158(8):2046-56. PubMed ID: 20050195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
